Steve Stranne is a physician and lawyer who advises companies, health care organizations, professional societies, start-ups and patient advocacy organizations when Medicare coverage, coding or reimbursement decisions affect payment and access for medical technologies and services. He represents clients in reimbursement, coverage, coding, health care policy and patient access matters involving federal and state agencies.

Steve’s work focuses on the clinical, economic and policy issues that shape how medical technologies and services are covered, coded, paid for and made available to patients. He interprets and shapes clinical literature, legislation, regulations and coverage policies, and presents clinical and scientific issues to policymakers and decision-makers within federal and state agencies. He works with clients to understand the interplay between clinical, economic and political stakeholders and to develop arguments tailored to each audience.

Steve advocates for clients before the U.S. Congress, the Centers for Medicare & Medicaid Services (CMS), Medicare Administrative Contractors, including DME MACs, the Food and Drug Administration (FDA), and other agencies within the U.S. Department of Health and Human Services (HHS). His work includes developing policies, legislative language, comments, position papers and advocacy strategies affecting regulatory and reimbursement frameworks.

He works with organizational clients to identify legislative and regulatory objectives aligned with their mission or business goals, build internal consensus when necessary and coordinate across legal and policy functions, including patent, copyright, FDA, corporate and health care compliance considerations.

Education

  • Harvard Law School (J.D., 1994)
    • Duke University Medical School (M.D., 1990)
      • Duke University (B.S.E., 1986)
        • Mechanical Engineering

      Bar Admission

      • District of Columbia

      Professional Affiliations

      • American Health Lawyers Association, Member

      Recognition

      • Recognized by LMG Life Sciences for Medical Device and Health Care Pricing and Reimbursement, 2012-2025
      • Selected for inclusion in Best Lawyers in America® for Health Care Law, 2025-2026
      Publications
      Beyond the Pump: The Iran War’s Adverse Impact on U.S. Health Care
      Key Takeaways The closure of the Strait of Hormuz following the U.S.-Iran conflict is disrupting global health care supply chains and increasing costs for critical medical products. Shortages and delays are already affecting pharmaceuticals, MRI-related helium supplies and cold-chain products. The disruptions create operational and financial pressure for health care providers that depend on imported drugs, medical equipment and time-sensitive supplies. Rising freight, fuel and insurance costs are contributing to higher prices and longer lead times across multiple product categories. Health care organizations should closely monitor supply availability, transportation delays and pricing volatility tied to the ongoing conflict and shipping restrictions. Providers may need to evaluate inventory levels, supplier diversification and contingency planning for critical medical inputs. Since the beginning of the United States’
      Read More
      Election Year Politics and Policy at CMMI: What Stakeholders Can Expect
      Key Takeaways CMS’ Innovation Center is accelerating new payment and care delivery models as the Trump administration uses CMMI to advance health policy priorities. Current models target areas such as chronic care, behavioral health, drug pricing and value-based care. CMMI remains a powerful policy vehicle, but its recent pace has drawn renewed scrutiny over cost savings, scale and taxpayer value. That debate could shape oversight, legislation and expectations for how future models are designed and evaluated. Health care stakeholders should continue tracking CMMI closely as participation opportunities expand and mandatory models create new operational demands. Organizations should assess where engagement, compliance planning or advocacy may be needed as models evolve. The Centers for Medicare & Medicaid Services (CMS) is currently pursuing approximately 35 models
      Read More